Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Kinetic analysis of changes in T- and B-lymphocytes after anti-CD20 treatment in renal pathology.

Immunobiology - 1 Apr 2017

Sentís Alexis, Diekmann Fritz, Llobell Arturo, de Moner Noemí, Espinosa Gerard, Yagüe Jordi, Campistol Josep Maria, Mirapeix Eduard, Juan Manel

Abstract excerpt

INTRODUCTION: The main objective of this study is to describe qualitatively and quantitatively the different immune lymphocyte phenotypes of patients with renal disease after treatment with anti-CD20. MATERIAL AND METHODS: Two cohorts of transplanted and autoimmune kidney patients were compared: (1) Those who began treatment with Rituximab, matched (for sex, age and general clinical parameters) with (2)...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to B-Lymphocyte Subsets
Share to Immunologic Factors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Kidney Diseases

Share to Kidney Transplantation

Share to Lymphocyte Count

Share to Receptors, IgG

Share to Rituximab

Share to T-Lymphocyte Subsets

Source

Identifiers

PMID: 27986304
DOI: 10.1016/j.imbio.2016.11.011

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Kinetic analysis of changes in T- and B-lymphocytes after anti-CD20 treatment in renal pathology.PMID 27986304Read ↗

Longitudinal analysis of T and B cell phenotype and function in renal transplant recipients with or without rituximab induction therapy.Semantic proximity Read ↗

Rituximab in Systemic Lupus Erythematosus: Transient Effects on Autoimmunity Associated Lymphocyte Phenotypes and Implications for Immunogenicity.Semantic proximity Read ↗

Single-cell level characterization of B cell depletion and repopulation following rituximab in systemic lupus erythematosusSemantic proximity Read ↗

B- and T-cell subpopulations in patients with severe idiopathic membranous nephropathy may predict an early response to rituximab.Semantic proximity Read ↗

A single dose of rituximab does not deplete B cells in secondary lymphoid organs but alters phenotype and function.Semantic proximity Read ↗

Phenotypic and Transcriptomic Lymphocytes Changes in Allograft Recipients After Intravenous Immunoglobulin Therapy in Kidney Transplant Recipients.Semantic proximity Read ↗

Pharmacokinetic characterization of rituximab in patients with glomerular diseasesSemantic proximity Read ↗

Phenotypic evaluation of B-cell subsets after rituximab for treatment of acute renal allograft rejection in pediatric recipients.Semantic proximity Read ↗

Short- and long-term effects of anti-CD20 treatment on B cell ontogeny in bone marrow of patients with rheumatoid arthritis.Semantic proximity Read ↗

Depletion of functionally active CD20+ T cells by rituximab treatment.Semantic proximity Read ↗

The immunological phenotype of rituximab-sensitive chronic graft-versus-host disease: a phase II study.Semantic proximity Read ↗

Novel strategies to target the humoral alloimmune response.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.